| ||||||
![]() |
| | LinkBack | Thread Tools | Display Modes |
|
#1
| |||
| |||
|
Mylan announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received tentative approval from the FDA under the President's Emergency Plan for AIDS Relief for its New Drug Application for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, 600 mg/300 mg/300 mg. :
|
![]() |
| Thread Tools | |
| Display Modes | |
| |